Benzododecinium

This classification denotes a topical anti-infective agent with the molecular formula C21H38N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N0BN0O8CSL, chemically known as n-dodecyl-n, n-dimethylbenzenemethanaminium chloride but generally known as benzododecinium, which bears US NIH Compound Identifier 8754. Benzododecinium most often comes in base, bromatum, bromide, and chloride forms. European Medicines Agency schedules Benzododecinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00724MIG. World Health Organization schedules benzododecinium in its Anatomical Therapeutic Chemical (ATC) Classification. BENZODODECINIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BENZODODECINIUM remains the US FDA Preferred Term for this commodity. Benzododecinium bears US NLM identifiers UMLS ID C0058263 and NCI Concept Code C79723. SMILES: [N](CCCCCCCCCCCC)(CC1CCCCC1)(C)C. .